Crossref
journal-article
American Society of Hematology
Blood (234)
References
296
Referenced
467
10.1152/ajplegacy.1949.156.2.261
/ Am J Physiol / Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. by Roche e Silva (1949)10.1172/JCI108247
/ J Clin Invest / Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. by Colman (1975)10.1172/JCI108248
/ J Clin Invest / Flaujeac trait. Deficiency of human plasma kininogen. by Wuepper (1975)10.1172/JCI108009
/ J Clin Invest / Fitzgerald trait: Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/DIL). by Saito (1975)10.1016/S0021-9258(17)39515-7
/ J Biol Chem / Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens. by Takagaki (1985)10.1016/S0021-9258(17)39516-9
/ J Biol Chem / Structural organization of the human kininogen gene and a model for its evolution. by Kitamura (1985)10.1007/BF00204179
/ Hum Genet / The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction. by Fong (1991)10.1159/000133192
/ Cytogenet Cell Genet / Chromosomal mapping of human kininogen gene (KNG) to 3q26→qter. by Cheung (1992)10.1159/000133984
/ Cytogenet Cell Genet / Three members of the human cystatin gene superfamily, AHSG, HRG, and KNG, map within one megabase of genomic DNA at 3q27. by Rizzu (1995)10.1016/S0021-9258(19)38785-X
/ J Biol Chem / A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen genes. by Kakizuka (1990)10.1016/S0021-9258(19)49471-4
/ J Biol Chem / Genetic basis of total kininogen deficiency in Williams' trait. by Cheung (1993)10.1016/S0021-9258(19)85325-5
/ J Biol Chem / A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. by Hayashi (1993)10.1016/0167-4781(92)90069-C
/ Biochim Biophys Acta / Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. by Chen (1992){'key': '2019111912390634900_B14', 'first-page': '112', 'article-title': 'Immunoblotting of plasma in a pregnant patient with hereditary angioedema.', 'volume': '115', 'author': 'Chhibber', 'year': '1990', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Immunoblotting of plasma in a pregnant patient with hereditary angioedema. by Chhibber (1990)10.1016/0167-4889(94)00218-4
/ Biochim Biophys Acta / Murine fibroblasts synthesize and secrete kininogen in response to cyclic-AMP, prostaglandin E2 and tumor necrosis factor. by Takano (1995){'key': '2019111912390634900_B16', 'first-page': '77', 'article-title': 'Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody.', 'volume': '119', 'author': 'Scott', 'year': '1992', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody. by Scott (1992){'key': '2019111912390634900_B17', 'first-page': '25', 'article-title': 'Some data on two purified kininogens from human plasma.', 'volume': '29', 'author': 'Jacobsen', 'year': '1967', 'journal-title': 'Br J Pharmacol'}
/ Br J Pharmacol / Some data on two purified kininogens from human plasma. by Jacobsen (1967)10.1172/JCI112472
/ J Clin Invest / High molecular weight kininogen is an inhibitor of platelet calpain. by Schmaier (1986)10.1172/JCI110901
/ J Clin Invest / High-molecular weight kininogen. A secreted platelet protein. by Schmaier (1983)10.1016/S0021-9258(18)37596-3
/ J Biol Chem / The expression of high molecular weight kininogen on human umbilical vein endothelial cells. by Schmaier (1988)10.1172/JCI114151
/ J Clin Invest / Human neutrophils contain and bind high molecular weight kininogen. by Gustafson (1989)10.1016/S0021-9258(19)68671-0
/ J Biol Chem / Characterization and localization of human renal kininogen. by Proud (1981)10.1515/bchm3.1987.368.2.1151
/ Biol Chem Hoppe Seyler / Quantification of kininogen in human renal medulla. by Hallbach (1987)10.1016/0167-4838(87)90178-6
/ Biochim Biophys Acta / Interstitial-tissue localization of high-molecular-weight kininogen in guinea-pig skin. by Yamamoto (1987)10.1021/bi00319a005
/ Biochemistry / Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. by Ohkubo (1984)10.1016/S0021-9258(17)36995-8
/ J Biol Chem / The shape of high molecular weight kininogen: Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. by Weisel (1994)10.1042/bj2340429
/ Biochem J / Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. by Salvesen (1986)10.1016/S0021-9258(19)75800-1
/ J Biol Chem / Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. by Schmaier (1987)10.1016/S0021-9258(18)37804-9
/ J Biol Chem / Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions. by Vogel (1988)10.1016/S0021-9258(19)74347-6
/ J Biol Chem / Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain. by Bradford (1993)10.1182/blood.V85.11.3134.bloodjournal85113134
/ Blood / High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium. by Hasan (1995)10.1055/s-0038-1649886
/ Thromb Haemost / Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells. by Hasan (1995)10.1083/jcb.116.2.465
/ J Cell Biol / Inhibition of cell adhesion by high molecular weight kininogen. by Asakura (1992)10.1021/bi00396a025
/ Biochemistry / Heavy chain of human high molecular weight and low molecular weight kininogen binds calcium ion. by Ishiguro (1987)10.1182/blood.V81.11.2936.2936
/ Blood / Bradykinin regulates the expression of kininogen binding sites on endothelial cells. by Zini (1993)10.1172/JCI112567
/ J Clin Invest / High molecular weight kininogen binds to unstimulated platelets. by Gustafson (1986)10.1021/bi00361a022
/ Biochemistry / Binding of coagulation factor XI to washed human platelets. by Greengard (1986)10.1016/S0021-9258(18)68839-8
/ J Biol Chem / The binding of high molecular weight kininogen to cultured human endothelial cells. by van Iwaarden (1988){'key': '2019111912390634900_B39', 'first-page': '1162', 'article-title': 'Digestive process and regulation of renal excretory function. Pepsanurin and prokinins inhibitors of diuresis mediated by atrial natriuretic peptide.', 'volume': '122', 'author': 'Croxatto', 'year': '1995', 'journal-title': 'Rev Med Chile'}
/ Rev Med Chile / Digestive process and regulation of renal excretory function. Pepsanurin and prokinins inhibitors of diuresis mediated by atrial natriuretic peptide. by Croxatto (1995)10.1042/bj2700083
/ Biochem J / Kinetics of inhibition of platelet calpain II by human kininogens. by Bradford (1990)10.1016/0014-5793(93)80628-8
/ FEBS Lett / Cloning, expression and characterization of human kininogen domain 3. by Auerswald (1993)10.1016/0014-5793(94)01380-J
/ FEBS Lett / Interaction of cysteine proteinases with recombinant kininogen domain 2, expressed in Escherichia coli. by Ylinenjarvi (1995)10.1007/BF01908533
/ J Protein Chem / Structural requirements for cathepsin B and cathepsin H inhibition by kininogens. by Bano (1996)10.1016/S0021-9258(18)53048-9
/ J Biol Chem / Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. by Scott (1993)10.1182/blood.V67.1.119.bloodjournal671119
/ Blood / High molecular weight kininogen: Localization in the unstimulated and activated platelet and activation by a platelet calpain(s). by Schmaier (1986)10.1182/blood.V75.6.1273.1273
/ Blood / Membrane expression of platelet calpain. by Schmaier (1990)10.1016/S0021-9258(18)53191-4
/ J Biol Chem / In situ capture of m-calpain activation of platelets. by Saido (1993)10.1016/S0021-9258(20)89569-6
/ J Biol Chem / Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. by Meloni (1991)10.1182/blood.V81.5.1306.1306
/ Blood / Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. by Reddigari (1993)10.1016/S0021-9258(19)50583-X
/ J Biol Chem / Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. by Jiang (1992)10.1016/S0021-9258(17)32168-3
/ J Biol Chem / High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). by Wachtfogel (1994)10.1002/j.1460-2075.1988.tb03109.x
/ EMBO J / The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. by Bode (1988)10.1016/S0021-9258(18)92103-4
/ J Biol Chem / Identification of an endothelial cell binding site on kininogen domain D3. by Herwald (1995)10.1055/s-0038-1648823
/ Thromb Haemost / Platelet thrombospondin interactions with human high and low molecular weight kininogens. by DeLa (1994)10.1182/blood.V77.3.500.500
/ Blood / High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. by Puri (1991)10.1161/01.CIR.94.3.517
/ Circulation / Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of α-thrombin-induced platelet activation. by Hasan (1996)10.1074/jbc.271.19.11228
/ J Biol Chem / Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 domain 3 in the heavy chain of high molecular weight kininogen. by Kunapuli (1996)10.1093/oxfordjournals.jbchem.a133339
/ J Biochem / Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. by Mori (1981){'key': '2019111912390634900_B59', 'first-page': '182', 'article-title': 'Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.', 'volume': '112', 'author': 'Schmaier', 'year': '1988', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. by Schmaier (1988)10.1016/S0021-9258(17)34010-3
/ J Biol Chem / Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. by Tayeh (1994)10.1016/S0021-9258(18)32151-3
/ J Biol Chem / Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. by Wiggins (1983)10.1016/S0021-9258(19)85161-X
/ J Biol Chem / Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function. by Scott (1985)10.1515/bchm3.1988.369.2.1009
/ Biol Chem Hoppe Seyler / Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase. by Sato (1988)10.1084/jem.167.6.1895
/ J Exp Med / Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity. by Kleniewski (1988)10.1016/S0021-9258(18)31769-1
/ J Biol Chem / The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. by Hasan (1994)10.1182/blood.V79.5.1233.1233
/ Blood / High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. by Meloni (1992)10.1074/jbc.270.33.19256
/ J Biol Chem / Mapping the cell binding site on high molecular weight kininogen domain 5. by Hasan (1995){'key': '2019111912390634900_B68'}
10.1016/S0021-9258(18)61470-X
/ J Biol Chem / Effects of chemical modifications on the surface- and protein-binding properties of the light chain of human high molecular weight kininogen. by Retzios (1987)10.1016/S0021-9258(18)53802-3
/ J Biol Chem / Deletion mutagenesis of high molecular weight kininogen light chain: Identification of two anionic surface binding subdomains. by Kunapuli (1993)10.1021/bi00429a039
/ Biochemistry / Binding of heparin to human high molecular weight kininogen. by Bjork (1989)10.1002/pro.5560010115
/ Protein Sci / The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. by DeLa (1992)10.1042/bj3050173
/ Biochem J / Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. by Ben (1995)10.1172/JCI111319
/ J Clin Invest / Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. by Scott (1984)10.1016/S0021-9258(18)66724-9
/ J Biol Chem / Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity. by Tait (1986)10.1016/S0021-9258(18)60859-2
/ J Biol Chem / Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. by Tait (1987)10.1016/S0021-9258(19)38373-5
/ J Biol Chem / Mapping of the prekallikrein binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries: Mimicking of the predicted binding site by anti-idiotypic antibodies. by Vogel (1990)10.1016/S0021-9258(17)43773-2
/ J Biol Chem / Protein-protein interactions in contact activation of blood coagulation. Characterization of fluorescein-labeled human high molecular weight kininogen-light chain as a probe. by Bock (1983)10.1016/S0021-9258(17)38892-0
/ J Biol Chem / Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains. by Bock (1985)10.1007/BF01025019
/ J Protein Chem / Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen. by Scarsdale (1990)10.1007/BF01025629
/ J Protein Chem / Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen. by You (1991)10.1016/0196-9781(93)90061-K
/ Peptides / Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen. by You (1993)10.1182/blood.V74.2.695.695
/ Blood / Monoclonal antibody to human high molecular weight kininogen recognizes its prekallikrein binding site and inhibits coagulant activity. by Reddigari (1989)10.1016/S0021-9258(18)52980-X
/ J Biol Chem / Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties. by Kaufmann (1993)10.1055/s-0038-1649800
/ Thromb Haemost / Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. by Lenich (1995){'key': '2019111912390634900_B86'}
10.1021/bi00220a027
/ Biochemistry / Gene structure and chromosomal localization of plasma kallikrein. by Beaubien (1991)10.1021/bi00397a004
/ Biochemistry / Organization of the gene for human factor XI. by Asakai (1987)10.1021/bi00357a017
/ Biochemistry / Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. by Chung (1986)10.1021/bi00222a007
/ Biochemistry / Location of the disulfide bonds in human plasma prekallikrein: The presence of four novel apple domains in the amino-terminal portion of the molecule. by McMullen (1991)10.1021/bi00222a008
/ Biochemistry / Location of the disulfide bonds in human coagulation factor XI: The presence of a Tandem apple domain. by McMullen (1991)10.1016/S0021-9258(17)40034-2
/ J Biol Chem / Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. by Mandle (1977)10.1111/j.1432-1033.1979.tb02035.x
/ Eur J Biochem / Human plasma prekallikrein: A rapid high yield method for purification. by Scott (1979)10.1182/blood.V59.5.963.bloodjournal595963
/ Blood / Assay of prekallikrein in human plasma: Comparison of amidolytic, esterolytic, coagulation, and immunochemical assays. by Fisher (1982)10.1111/j.1476-5381.1970.tb10591.x
/ Br J Pharmacol / The isolation of human plasma prekallikrein. by McConnell (1970)10.1084/jem.135.1.1
/ J Exp Med / Plasma prekallikrein: Isolation, characterization, and mechanism of action. by Wuepper (1972)10.1016/S0021-9258(17)42473-2
/ J Biol Chem / Human plasma prekallikrein: Immunoaffinity purification and activation to α- and β-kallikrein. by Burger (1986)10.1182/blood.V65.2.311.bloodjournal652311
/ Blood / Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. by Colman (1985)10.1073/pnas.73.11.4179
/ Proc Natl Acad Sci USA / Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. by Mandle (1976)10.1016/S0021-9258(18)92953-4
/ J Biol Chem / Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). by Page (1991)10.1006/abbi.1994.1424
/ Arch Biochem Biophys / Localization of the binding site on plasma kallikrein for high molecular weight kininogen to both apple 1 and apple 4 domains of the heavy chain. by Page (1994){'key': '2019111912390634900_B102'}
10.1021/bi960547j
/ Biochemistry / Direct evidence for multi-facial contacts between high molecular weight kininogen and plasma prekallikrein. by Lin (1996)10.1074/jbc.271.22.13061
/ J Biol Chem / Mapping of the discontinuous kininogen binding site of prekallikrein. by Herwald (1996)10.4049/jimmunol.104.3.574
/ J Immunol / Interaction of plasma kallikrein with the C1 inhibitor. by Gigli (1970)10.1172/JCI110743
/ J Clin Invest / Inactivation of Kallikrein in plasma. by Van der Graff (1983)10.1172/JCI110470
/ J Clin Invest / Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. by Schapira (1982)10.1021/bi00289a037
/ Biochemistry / Interaction of human plasma, kallikrein and its light chain with C1 inhibitor. by Van der Graff (1983)10.1021/bi00532a024
/ Biochemistry / High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. by Schapira (1982)10.1021/bi00513a006
/ Biochemistry / Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. by Schapira (1981){'key': '2019111912390634900_B111', 'first-page': '882', 'article-title': 'Plasma prekallikrein assay: Reversible inhibition of C1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.', 'volume': '104', 'author': 'Schmaier', 'year': '1984', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Plasma prekallikrein assay: Reversible inhibition of C1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species. by Schmaier (1984)10.1016/0003-9861(76)90567-1
/ Arch Biochem Biophys / Antithrombin-heparin cofactor: An inhibitor of plasma Kallikrein. by Lahiri (1976)10.1021/bi00412a005
/ Biochemistry / Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. by Meijers (1988)10.1055/s-0038-1647452
/ Thromb Haemost / Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma. by Espana (1991)10.1182/blood.V73.4.994.994
/ Blood / Plasminogen activators in dextran sulfate-activated euglobulin functions: A molecular analysis of factor XII and prekallikrein-dependent fibrinolysis. by Hauert (1989)10.1016/S0021-9258(17)35674-0
/ J Biol Chem / The activation of prourokinase by plasma kallikrein and its inactivation by thrombin. by Ichinose (1986)10.1007/BF00273661
/ Hum Genet / Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids. by Citarella (1988)10.1007/BF01534407
/ Somat Cell Mol Genet / Structural gene encosing human factor XII is located at 5q33-qter. by Rolye (1988)10.1016/S0021-9258(19)76478-3
/ J Biol Chem / Characterization of the human blood coagulation factor XII gene. by Cool (1987)10.1016/S0021-9258(17)38776-8
/ J Biol Chem / Characterization of human blood coagulation factor XII cDNA. by Cool (1985)10.1021/bi00355a009
/ Biochemistry / Characterization of a cDNA coding for human factor XII (Hageman factor). by Que (1986)10.1016/S0076-6879(76)45009-7
/ Methods Enzymol / Human factor XII (Hageman factor). by Griffin (1976)10.1172/JCI107799
/ J Clin Invest / Structural changes accompanying enzymatic activation of Hageman factor. by Revak (1974){'key': '2019111912390634900_B124', 'first-page': '506', 'article-title': 'Radioimmunoassay of human Hageman factor (factor XII).', 'volume': '88', 'author': 'Saito', 'year': '1976', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Radioimmunoassay of human Hageman factor (factor XII). by Saito (1976){'key': '2019111912390634900_B125', 'first-page': '463', 'article-title': 'Hepatocytes express blood coagulation factor XII (Hageman factor).', 'volume': '115', 'author': 'Gordon', 'year': '1990', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Hepatocytes express blood coagulation factor XII (Hageman factor). by Gordon (1990){'key': '2019111912390634900_B126', 'first-page': '52', 'article-title': 'Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.', 'volume': '111', 'author': 'Gordon', 'year': '1988', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. by Gordon (1988)10.1055/s-0038-1645045
/ Thromb Haemost / The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII. by Mitropoulos (1990){'key': '2019111912390634900_B128', 'first-page': '353', 'article-title': 'Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen-and prolactin-treated rats.', 'volume': '117', 'author': 'Gordon', 'year': '1991', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen-and prolactin-treated rats. by Gordon (1991)10.1210/endo.136.11.7588244
/ Endocrinology / Molecular basis of estrogen regulation of Hageman factor XII gene expression. by Farsetti (1995)10.1073/pnas.88.10.4382
/ Proc Natl Acad Sci USA / Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. by Schmeidler-Sapiro (1991)10.1073/pnas.93.5.2174
/ Proc Natl Acad Sci USA / Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. by Gordon (1996)10.1016/S0021-9258(18)61089-0
/ J Biol Chem / A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation. by Pixley (1987)10.1016/S0021-9258(18)60491-0
/ J Biol Chem / Mapping of a putative surface-binding site of human coagulation factor XII. by Clarke (1989)10.1111/j.1432-1033.1996.0240q.x
/ Eur J Biochem / Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces. by Citrella (1996)10.1084/jem.138.6.1564
/ J Exp Med / Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. by Cochrane (1973)10.1016/S0021-9258(18)41830-3
/ J Biol Chem / Human factor XII (Hageman factor) autoactivation by dextran sulfate: Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. by Samuel (1992)10.1182/blood.V66.1.198.bloodjournal661198
/ Blood / Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III. by Pixley (1985)10.1073/pnas.86.21.8319
/ Proc Natl Acad Sci USA / Coagulation factor XII (Hageman factor) Washington DC: Inactive factor XIIa results from Cys571 to Ser substitution. by Miyata (1989)10.1182/blood.V78.4.997.997
/ Blood / Functional characterization of an abnormal factor XII molecule (F XII Bern). by Wuillemin (1991)10.1084/jem.138.6.1564
/ J Exp Med / Activation of Hageman factor in solid and fluid phases: A critical role of kallikrein. by Cochrane (1973)10.1172/JCI108741
/ J Clin Invest / The binding and cleavage characteristics of huma Hageman factor during contact activation: a comparison of normal plasma with plasma deficient in factor XI, prekallikrein or high molecular weight kininogen. by Revak (1977)10.1073/pnas.75.4.1998
/ Proc Natl Acad Sci USA / The role of surface in the surface-dependent activation of Hageman factor (blood coagulation factor XII). by Griffin (1978)10.1182/blood.V61.4.652.652
/ Blood / The binding of bovine factor XII to kaolin. by Kirby (1983)10.1084/jem.150.5.1122
/ J Exp Med / The autoactivation of rabbit Hageman factor. by Wiggins (1979)10.1016/0006-291X(80)90774-3
/ Biochem Biophys Res Commun / Autoactivability of human Hageman factor. by Miller (1980)10.1016/S0021-9258(20)79699-7
/ J Biol Chem / Autoactivation of human Hageman factor: Demonstration utilizing a synthetic substrate. by Silverberg (1980)10.1016/S0021-9258(19)68105-6
/ J Biol Chem / The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. by Dunn (1982){'key': '2019111912390634900_B148', 'first-page': '31', 'article-title': 'Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.', 'volume': '102', 'author': 'Espana', 'year': '1983', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. by Espana (1983)10.1021/bi00297a016
/ Biochemistry / Kinetics of activation and autoactivation of human factor XII. by Tankersley (1984)10.1097/00001721-199310000-00002
/ Blood Coagul Fibrinolysis / Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). by Schousboe (1993)10.1016/S0021-9258(18)31412-1
/ J Biol Chem / Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. by Bernardo (1993)10.1016/S0021-9258(18)31413-3
/ J Biol Chem / Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. by Bernardo (1993)10.1111/j.1432-1033.1997.00491.x
/ Eur J Biochem / Identification of the Zn2+ binding sites in factor XII and its activation derivatives. by Rojkjaer (1997)10.1172/JCI109651
/ J Clin Invest / Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. by Wiggins (1980)10.1016/S0021-9258(19)43251-1
/ J Biol Chem / Isolation of the high molecular weight activators of prekallikrein. by Bagdasarian (1973)10.4049/jimmunol.105.4.802
/ J Immunol / A prealbumin activator of prekallikrein. by Kaplan (1970)10.4049/jimmunol.105.5.1307
/ J Immunol / Plasma Kinin system: Proenzyme components. by Wuepper (1970)10.1016/0002-9343(79)90253-5
/ Am J Med / Molecular assembly in the contact phase of the Hageman factor system. by Cochrane (1979)10.1084/jem.133.4.696
/ J Exp Med / A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. by Kaplan (1971)10.1084/jem.147.3.719
/ J Exp Med / Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. by Revak (1978)10.1172/JCI108361
/ J Clin Invest / The relationship of structure and function in human Hageman factor. The association of enzymatic binding activities with separate regions of the molecule. by Revak (1976){'key': '2019111912390634900_B162', 'first-page': '809', 'article-title': 'Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1-inactivator.', 'volume': '76', 'author': 'Forbes', 'year': '1970', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1-inactivator. by Forbes (1970)10.1172/JCI107313
/ J Clin Invest / Inhibition by C1-INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin-generation. by Schreiber (1973)10.1172/JCI111360
/ J Clin Invest / Inactivation of factor XII active fragment in normal plasma: Predominant role of C1-inhibitor. by de Agostini (1984)10.1016/S0021-9258(18)89653-3
/ J Biol Chem / The regulation of human factor XIIa by plasma proteinase inhibitors. by Pixley (1985)10.1016/0003-9861(87)90606-0
/ Arch Biochem Biophys / Effect of negatively charged activating compounds on inactivation of factor XIIa by C1 inhibitor. by Pixley (1987)10.1016/S0021-9258(17)32973-3
/ J Biol Chem / The inhibition of human activated Hageman factor (HF ) by human antithrombin-heparin cofactor (AT). by Stead (1976)10.1182/blood.V66.1.198.bloodjournal661198
/ Blood / Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III. by Pixley (1985)10.1016/S0021-9258(18)80127-2
/ J Biol Chem / Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. by Berrettini (1989)10.1073/pnas.90.1.198
/ Proc Natl Acad Sci USA / Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. by Kleniewski (1993)10.1021/bi00321a090
/ Biochemistry / Receptors for high molecular weight kininogen on stimulated washed human platelets. by Greengard (1984)10.1182/blood.V71.5.1268.bloodjournal7151268
/ Blood / High-molecular weight kininogen is present in cultured human endothelial cells: Localization, isolation, and characterization. by van Iwaarden (1988)10.1111/j.1365-2141.1984.tb03955.x
/ Br J Haematol / Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. by Kerbiriou-Nabias (1984)10.1182/blood.V79.3.754.754
/ Blood / Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. by Figueroa (1992)10.1083/jcb.109.1.377
/ J Cell Biol / High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. by Gustafson (1989)10.1016/S0021-9258(19)88630-1
/ J Biol Chem / Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. by Berrettini (1992)10.1073/pnas.78.7.4046
/ Proc Natl Acad Sci USA / On the attribution and additivity of binding energies. by Jencks (1981)10.1016/S0006-291X(89)80178-0
/ Biochem Biophys Res Commun / Conformation of high molecular weight kininogen: Effects of kallikrein and factor XIa cleavage. by Villanueva (1989)10.1073/pnas.80.12.3734
/ Proc Natl Acad Sci USA / Permanent cell lines expressing human factor VIII-related antigen established by hybridization. by Edgell (1983)10.1074/jbc.271.22.13040
/ J Biol Chem / Isolation and characterization of the kininogen-binding protein p33 from endothelial cells: Identity with the gC1q receptor. by Herwald (1996)10.1084/jem.179.6.1809
/ J Exp Med / Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular “heads” of C1q. by Ghebrehiwet (1994)10.1073/pnas.93.16.8552
/ Proc Natl Acad Sci USA / Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular “heads” of C1q (gC1qR). by Joseph (1996){'key': '2019111912390634900_B183'}
10.1016/S0021-9258(19)50297-6
/ J Biol Chem / Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. by Reddigari (1993){'key': '2019111912390634900_B185'}
10.1126/science.273.5281.1551
/ Science / Regulation of integrin function by the urokinase receptor. by Wei (1996){'key': '2019111912390634900_B186a'}
{'key': '2019111912390634900_B187'}
10.1242/jcs.108.3.1071
/ J Cell Sci / A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surface of hepatocytes, HepG2 cells, and breast carcinoma cell line. by Hembrough (1995)10.1074/jbc.271.41.25684
/ J Biol Chem / Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. by Hembrough (1996)10.1182/blood.V80.8.1980.1980
/ Blood / Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. by Nishikawa (1992)10.1172/JCI111361
/ J Clin Invest / Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. by Sinha (1984)10.1182/blood.V68.1.225.bloodjournal681225
/ Blood / Functional characterization of platelet-bound factor XIa: Retention of factor XIa activity on the platelet surface. by Walsh (1986)10.1055/s-0038-1642441
/ Thromb Haemost / Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. by Loza (1994)10.1084/jem.135.1.81
/ J Exp Med / A prealbumin activator of prekallikrein II. Appearance of chemotactic activity for human neutrophils by the conversion of prekallikrein to kallikrein. by Kaplan (1972)10.1172/JCI110557
/ J Clin Invest / Purified human plasma kallikrein aggregates human blood neutrophils. by Schapira (1982)10.1172/JCI111126
/ J Clin Invest / Human plasma kallikrein releases neutrophil elastase during blood coagulation. by Wachtfogel (1983)10.1055/s-0038-1647130
/ Thromb Haemost / Purified human plasma kallikrein does not stimulate but primes neutrophils for superoxide production. by Zimmerli (1989)10.1172/JCI110482
/ J Clin Invest / Leukocyte elastase release during blood coagulation: A potential mechanism for activation of the alternative fibrinolytic pathway. by Plow (1982)10.1093/ajcp/79.4.405
/ Am J Clin Pathol / The skin window as a monitor of leukocytic functions in contact activation factor deficiencies in man. by Rebuck (1983)10.1182/blood.V65.2.311.bloodjournal652311
/ Blood / Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. by Colman (1985)10.1182/blood.V67.6.1731.bloodjournal6761731
/ Blood / Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. by Wachtfogel (1986)10.1172/JCI113765
/ J Clin Invest / Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. by Chien (1988){'key': '2019111912390634900_B203'}
10.1073/pnas.89.24.11969
/ Proc Natl Acad Sci USA / Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). by Toossi (1992)10.1016/0005-2760(83)90261-8
/ Biochim Biophys Acta / Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists. by Crutchley (1983)10.1016/0049-3848(80)90201-7
/ Thromb Res / Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein. by Hong (1980)10.1002/jcp.1041430104
/ J Cell Physiol / Bradykinin induces superoxide anion release from human endothelial cells. by Holland (1990)10.1182/blood.V66.4.835.bloodjournal664835
/ Blood / Tissue plasminogen activator release in vivo in response to vasoactive agents. by Smith (1983)10.1055/s-0038-1656000
/ Thromb Haemost / Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. by Brown (1997)10.1038/327524a0
/ Nature / Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. by Palmer (1987)10.1172/JCI116907
/ J Clin Invest / Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. by Nakashima (1993)10.1111/j.1476-5381.1990.tb12105.x
/ Br J Pharmacol / Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. by Boulanger (1990){'key': '2019111912390634900_B213', 'first-page': '581', 'article-title': 'Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.', 'volume': '252', 'author': 'Schini', 'year': '1990', 'journal-title': 'J Pharmacol Exp Ther'}
/ J Pharmacol Exp Ther / Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells. by Schini (1990)10.1016/0014-5793(90)81445-T
/ FEBS Lett / Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. by Busse (1990)10.1172/JCI117005
/ J Clin Invest / Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. by Imai (1994){'key': '2019111912390634900_B216'}
{'key': '2019111912390634900_B217'}
10.1073/pnas.88.17.7724
/ Proc Natl Acad Sci USA / Expression cloning of a rat B2 bradykinin receptor. by McEachern (1991)10.1016/S0021-9258(17)31844-6
/ J Biol Chem / Expression cloning of a human B1 bradykinin receptor. by Menke (1994)10.1161/01.HYP.25.3.453
/ Hypertension / Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats. by Madeddu (1995)10.1093/cvr/28.2.166
/ Cardiovasc Res / Endothelial protection by converting enzyme inhibitors. by Wiemer (1994){'key': '2019111912390634900_B222', 'first-page': '183', 'article-title': 'Cardioprotection by angiotensin converting enzyme inhibitors-the experimental evidence.', 'volume': '28', 'author': 'Parratt', 'year': '1994', 'journal-title': 'Circ Res'}
/ Circ Res / Cardioprotection by angiotensin converting enzyme inhibitors-the experimental evidence. by Parratt (1994)10.1016/0022-2828(92)91103-C
/ Mol Cell Cardiol / ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. by Linz (1992){'key': '2019111912390634900_B224'}
10.1161/01.HYP.23.4.411
/ Hypertension / Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. by Gohlke (1994)10.1161/01.HYP.25.2.162
/ Hypertension / Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin. by O'Sullivan (1995)10.1152/jappl.1994.77.6.2675
/ J Appl Physiol / Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. by Siebeck (1994)10.1161/01.HYP.23.2.236
/ Hypertension / Human tissue kallikrein induces hypotension in transgenic mice. by Wang (1994)10.1074/jbc.270.1.451
/ J Biol Chem / Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. by Ma (1995)10.1042/bj2390325
/ Biochem J / Identification of a new tissue-kallikrein-binding protein. by Chao (1986)10.1016/S0021-9258(17)46236-3
/ J Biol Chem / Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. by Chao (1990)10.1016/S0021-9258(18)35690-4
/ J Biol Chem / Kallistatin: A novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. by Zhou (1992)10.1172/JCI117847
/ J Clin Invest / Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats [see comments]. by Wang (1995)10.1161/01.HYP.25.4.715
/ Hypertension / Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. by Xiong (1995){'key': '2019111912390634900_B235', 'first-page': '232', 'article-title': 'Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.', 'volume': '100', 'author': 'Puri', 'year': '1987', 'journal-title': 'Trans Assoc Am Phys'}
/ Trans Assoc Am Phys / Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen. by Puri (1987)10.1182/blood.V60.3.731.bloodjournal603731
/ Blood / Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: Alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s). by Coller (1982)10.1016/0006-291X(89)90775-4
/ Biochem Biophys Res Commun / Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine. by Puri (1989){'key': '2019111912390634900_B238', 'first-page': '32', 'article-title': 'Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.', 'volume': '7', 'author': 'Matsueda', 'year': '1994', 'journal-title': 'Pept Res'}
/ Pept Res / Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation. by Matsueda (1994)10.1172/JCI108841
/ J Clin Invest / Interrelations of platelet aggregation and secretion. by Charo (1977)10.1016/0049-3848(92)90010-8
/ Thromb Res / PPACK-thrombin is a noncompetitive inhibitor of alpha-thrombin binding to human platelets. by Schmaier (1992)10.1182/blood.V90.4.1508.1508_1508_1515
/ Blood / Human kininogens regulate thrombin binding to platelets through the GPIb-IX complex. by Bradford (1997)10.1016/0006-2952(93)90127-I
/ Biochem Pharmacol / Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. by Majima (1993)10.1254/jjp.60.111
/ Jpn J Pharmacol / A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. by Shima (1992)10.1055/s-0038-1654415
/ Thromb Diath Haemorrh / Role of the contact factor (Hageman factor) in fibrinolysis. by Niewiarowski (1959)10.1016/0006-291X(69)90278-2
/ Biochem Biophys Res Commun / Activation of plasminogen by human plasma kallikrein. by Colman (1969)10.1016/S0021-9258(17)40034-2
/ J Biol Chem / Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman-factor-dependent fibrinolysis. by Mandle (1977)10.1172/JCI109113
/ J Clin Invest / The activation of plasminogen by Hageman FXII (factor XII) and Hageman factor fragments. by Goldsmith (1978)10.1182/blood.V54.4.850.bloodjournal544850
/ Blood / Hageman-factor-dependent fibrinolysis: Generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. by Mandle (1979)10.1016/0014-5793(93)80537-5
/ FEBS Lett / Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis. by Gurewich (1993)10.1182/blood.V90.2.690
/ Blood / High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation. by Lin (1997)10.1074/jbc.270.29.17375
/ J Biol Chem / Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. by Higazi (1995)10.1055/s-0038-1655060
/ Thromb Diath Haemorrh / Possible involvement of fibrinogen and proteolysis in surface activation: A study with the recording ellipsometer. by Vroman (1967)10.1016/0049-3848(84)90154-3
/ Thromb Res / The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. by Schmaier (1984)10.1182/blood.V71.4.932.bloodjournal714932
/ Blood / Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: Role of the contact and fibrinolytic systems. by Brash (1988)10.1016/0162-3109(96)00003-3
/ Immunopharmacology / Neutrophil adhesion on surfaces preadsorbed with high molecular weight kininogen under well-defined flow conditions. by Yung (1996)10.1016/0002-9343(63)90162-1
/ Am J Med / Biochemical abnormality in hereditary angioneurotic edema. by Donaldson (1963)10.1084/jem.106.2.327
/ J Exp Med / Some properties of an esterase derived from preparations of the first component of complement. by Ratnoff (1955){'key': '2019111912390634900_B258'}
10.1056/NEJM198305053081802
/ N Engl J Med / Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. by Schapira (1983){'key': '2019111912390634900_B260', 'first-page': '38', 'article-title': 'Generation of plasmin during acute attacks of hereditary angioedema.', 'volume': '121', 'author': 'Cugno', 'year': '1993', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Generation of plasmin during acute attacks of hereditary angioedema. by Cugno (1993)10.1182/blood.V68.2.455.bloodjournal682455
/ Blood / Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunblotting with monoclonal antibodies. by Berrettini (1986)10.1016/0091-6749(83)90052-0
/ J Allergy Clin Immunol / Kinin formation in hereditary angioedema plasma: Evidence aginst kinin derivation from C2 and in support of “spontaneous” formation of bradykinin. by Fields (1983)10.1172/JCI103067
/ J Clin Invest / Effect of glass upon the activation of various plasma clotting factors. by Rapaport (1955)10.1055/s-0038-1649054
/ Thromb Diath Haemorrh / Cold-promoted activation of factor VII. III. Relation to the kallikrein system. by Gjonnaess (1972)10.1172/JCI109543
/ J Clin Invest / Activation of human factor VII in plasma and in purified systems. by Seligsohn (1979)10.1182/blood.V68.1.239.bloodjournal681239
/ Blood / The effect of C1 inhibitor upon Hageman factor autoactivation. by Weiss (1986)10.1093/infdis/151.6.1019
/ J Infect Dis / Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. by Kalter (1985)10.1056/NEJM198905043201809
/ N Engl J Med / The role of plasma proteases in septic shock. by Colman (1989){'key': '2019111912390634900_B269', 'first-page': '270', 'article-title': 'Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.', 'volume': '112', 'author': 'Carvalho', 'year': '1988', 'journal-title': 'J Lab Clin Med'}
/ J Lab Clin Med / Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. by Carvalho (1988){'key': '2019111912390634900_B270', 'first-page': '325', 'article-title': 'The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease.', 'volume': '26', 'author': 'Mason', 'year': '1971', 'journal-title': 'Thromb Diath Haemorrh'}
/ Thromb Diath Haemorrh / The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. by Mason (1971){'key': '2019111912390634900_B271', 'first-page': '539', 'article-title': 'Kinin activation in the blood of patients with sepsis.', 'volume': '143', 'author': "O'Donnell", 'year': '1976', 'journal-title': 'Surg Gynecol Obstet'}
/ Surg Gynecol Obstet / Kinin activation in the blood of patients with sepsis. by O'Donnell (1976)10.1172/JCI108938
/ J Clin Invest / Plasma kallikrein activation and inhibition during typhoid fever. by Colman (1978){'key': '2019111912390634900_B273', 'first-page': '237', 'article-title': 'Prekallikrein activation in the adult respiratory distress syndrome.', 'volume': '21', 'author': 'Schapira', 'year': '1985', 'journal-title': 'Bull Eur Physiopathol Respir'}
/ Bull Eur Physiopathol Respir / Prekallikrein activation in the adult respiratory distress syndrome. by Schapira (1985)10.1056/NEJM198804213181603
/ N Engl J Med / A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. by Rao (1988)10.1182/blood.V72.6.1841.1841
/ Blood / Quantification of plasma factor XIIa-Cl(−)-inhibitor and kallikrein-Cl(−)-inhibitor complexes in sepsis. by Nuijens (1988)10.1182/blood.V77.12.2660.2660
/ Blood / Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. by Kaufman (1991)10.1182/blood.V81.12.3313.3313
/ Blood / Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. by DeLa (1993){'key': '2019111912390634900_B278', 'first-page': '1', 'article-title': 'Activation of the contact system in lethal hypotensive bacteremia in a baboon model.', 'volume': '140', 'author': 'Pixley', 'year': '1992', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Activation of the contact system in lethal hypotensive bacteremia in a baboon model. by Pixley (1992)10.1172/JCI116201
/ J Clin Invest / The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. by Pixley (1993)10.1111/j.1749-6632.1989.tb22493.x
/ Ann NY Acad Sci / Effect of heparin on the inhibition of the contact system enzymes. by Colman (1989)10.1182/blood.V73.2.468.468
/ Blood / Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass. by Wachtfogel (1989)10.1016/S0022-5223(19)33735-3
/ J Thorac Cardiovasc Surg / Aprotinin inhibits the contact, neutrophil and platelet activation systems during simulated extracorporeal perfusion. by Wachtfogel (1993){'key': '2019111912390634900_B283'}
{'key': '2019111912390634900_B284'}
10.1096/fasebj.9.5.7896018
/ FASEB J / Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat. by DeLa (1995)10.1053/gast.1996.v110.pm8613052
/ Gastroenterology / Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. by Sartor (1996)10.1007/BF02091530
/ Dig Dis Sci / Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. by Stadnicki (1996)10.1182/blood.V87.6.2337.bloodjournal8762337
/ Blood / Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. by Jansen (1996)10.1097/00005792-198307000-00004
/ Medicine (Baltimore) / Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases [Review]. by Goodnough (1983)10.1016/0268-9499(87)90046-4
/ Fibrinolysis / Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. by Mannhalter (1987)10.1055/s-0038-1647467
/ Thromb Haemost / Thromboembolism and bleeding tendency in congenital factor XII deficiency: A study on 74 subjects from 14 Swiss families. by Lammle (1991)10.1055/s-0038-1656366
/ Thromb Haemost / The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. by Halbmayer (1992)10.1097/00001721-199210000-00006
/ Blood Coagul Fibrinolysis / Factor XII clotting activity and antigen levels in patients with thromboembolic disease. by von Kanel (1992)10.1111/j.1749-6632.1992.tb51648.x
/ Ann NY Acad Sci / Evidence for a role of factor XII-dependent fibrinolysis in cardiovascular diseases. by Jespersen (1992)10.1016/0735-1097(91)90879-E
/ J Am Coll Cardiol / Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled study. by Munkvad (1991)
Dates
Type | When |
---|---|
Created | 5 years, 10 months ago (Oct. 12, 2019, 5:35 p.m.) |
Deposited | 1 year, 11 months ago (Sept. 21, 2023, 11:45 a.m.) |
Indexed | 2 weeks, 1 day ago (Aug. 7, 2025, 5:04 p.m.) |
Issued | 27 years, 9 months ago (Nov. 15, 1997) |
Published | 27 years, 9 months ago (Nov. 15, 1997) |
Published Print | 27 years, 9 months ago (Nov. 15, 1997) |
@article{Colman_1997, title={Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes}, volume={90}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v90.10.3819}, DOI={10.1182/blood.v90.10.3819}, number={10}, journal={Blood}, publisher={American Society of Hematology}, author={Colman, Robert W. and Schmaier, Alvin H.}, year={1997}, month=nov, pages={3819–3843} }